BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 3472340)

  • 1. DNA content in renal cell carcinoma. A clinical study with special reference to tumor heterogeneity and prognosis.
    Ljungberg B
    Scand J Urol Nephrol Suppl; 1986; 100():1-47. PubMed ID: 3472340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor spread and DNA content in human renal cell carcinoma.
    Ljungberg B; Stenling R; Roos G
    Cancer Res; 1988 Jun; 48(11):3165-7. PubMed ID: 3365699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell proliferation in renal cell carcinoma. A clinical study with special reference to prognosis.
    Larsson P
    Scand J Urol Nephrol Suppl; 1994; 165():1-48. PubMed ID: 7871395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA cytophotometry in renal cell carcinoma: a significant prognostic factor?
    Feil G; Mittermüller B; Bichler KH; Wunderer A; Wechsel HW; Nelde HJ; St Krause F
    Anticancer Res; 1999; 19(2C):1483-6. PubMed ID: 10365128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA ploidy is a valuable predictor for prognosis of patients with resected renal cell carcinoma.
    Abou-Rebyeh H; Borgmann V; Nagel R; Al-Abadi H
    Cancer; 2001 Nov; 92(9):2280-5. PubMed ID: 11745282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of flow cytometric, static cytometry and tumor cytogenetic investigation results human renal cell carcinomas].
    Krech RH; Baretton G; Fonatsch C; Diebold J; Früchtnicht W; Löhrs U
    Verh Dtsch Ges Pathol; 1990; 74():228-32. PubMed ID: 1708590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of uPA, PAI-1, and DNA content in adult renal cell carcinoma.
    Chautard D; Dalifard I; Chassevent A; Guyetant S; Daver A; Vielle B; Soret JY
    Urology; 2004 Jun; 63(6):1055-60. PubMed ID: 15183949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA ploidy pattern in papillary renal cell carcinoma. Correlation with clinicopathological parameters and survival.
    del Vecchio MT; Lazzi S; Bruni A; Mangiavacchi P; Cevenini G; Luzi P
    Pathol Res Pract; 1998; 194(5):325-33. PubMed ID: 9651945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromodeoxyuridine and deoxyribonucleic acid bivariate analysis in human renal cell carcinoma. Does flow cytometric determination predict malignant potential or prognosis of patients with renal cell carcinoma?
    Tachibana M; Deguchi N; Baba S; Jitsukawa S; Hata M; Tazaki H
    Am J Clin Pathol; 1992 May; 97(5 Suppl 1):S38-47. PubMed ID: 1575219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo aneuploidization during the expansion of renal adenocarcinoma.
    Di Capua Sacoto C; Budia Alba A; Alapont Alacreu JM; Ruiz Cerda JL; Jimenez Cruz JF
    Urol Int; 2011; 86(4):466-9. PubMed ID: 21546757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric DNA-ploidy as a prognostic indicator in oral squamous cell carcinoma.
    Wang XL; Chen RM; Wang ZS; Chen WL; Zuo LF
    Chin Med J (Engl); 1990 Jul; 103(7):572-5. PubMed ID: 2119974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.
    Visscher DW; Zarbo RJ; Greenawald KA; Crissman JD
    Pathol Annu; 1990; 25 Pt 1():171-210. PubMed ID: 2153277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era.
    Clark PE; Veys JA; Eskridge MR; Woodruff RD; Hall MC
    Urol Oncol; 2005; 23(5):328-32. PubMed ID: 16144666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The in vivo DNA aneuploidization during expansion of conventional renal cell carcinoma.
    Li G; Cottier M; Sabido O; Gentil-Perret A; Lambert C; Passebosc-Faure K; Genin C; Tostain J
    In Vivo; 2002; 16(5):341-4. PubMed ID: 12494875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proliferating cell nuclear antigen (PCNA), immunostaining and flow cytometric DNA analysis of renal cell carcinoma.
    Tanioka F; Hiroi M; Yamane T; Hara H
    Zentralbl Pathol; 1993 Aug; 139(3):185-93. PubMed ID: 8105885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on flow cytometric analysis of nuclear DNA content in non-small cell lung cancer].
    Isobe H
    Hokkaido Igaku Zasshi; 1991 Jan; 66(1):49-58. PubMed ID: 1848524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Flow cytometric analysis of renal cell carcinoma].
    Lü GH
    Zhonghua Zhong Liu Za Zhi; 1990 Jan; 12(1):27-9. PubMed ID: 2364867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiparameter flow cytometric analysis of neoplasms of the central nervous system: correlation of nuclear antigen p105 and DNA content with clinical behavior.
    Appley AJ; Fitzgibbons PL; Chandrasoma PT; Hinton DR; Apuzzo ML
    Neurosurgery; 1990 Jul; 27(1):83-96. PubMed ID: 2377285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C; Bocsi J; Bartha I; Math J; Balazs G
    Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of DNA-aneuploidy subgroups and proliferation in renal cell carcinoma.
    Schafhauser W; Liedl T; Elsässer D; Zörcher T; Schrott KM
    Anticancer Res; 1999; 19(2C):1471-5. PubMed ID: 10365126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.